1. Home
  2. PDLB vs DCTH Comparison

PDLB vs DCTH Comparison

Compare PDLB & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDLB
  • DCTH
  • Stock Information
  • Founded
  • PDLB 1960
  • DCTH 1988
  • Country
  • PDLB United States
  • DCTH United States
  • Employees
  • PDLB N/A
  • DCTH N/A
  • Industry
  • PDLB
  • DCTH Medical/Dental Instruments
  • Sector
  • PDLB
  • DCTH Health Care
  • Exchange
  • PDLB Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • PDLB 316.6M
  • DCTH 426.3M
  • IPO Year
  • PDLB 2017
  • DCTH N/A
  • Fundamental
  • Price
  • PDLB $13.78
  • DCTH $11.03
  • Analyst Decision
  • PDLB
  • DCTH Strong Buy
  • Analyst Count
  • PDLB 0
  • DCTH 4
  • Target Price
  • PDLB N/A
  • DCTH $24.00
  • AVG Volume (30 Days)
  • PDLB 39.9K
  • DCTH 898.0K
  • Earning Date
  • PDLB 07-29-2025
  • DCTH 08-04-2025
  • Dividend Yield
  • PDLB N/A
  • DCTH N/A
  • EPS Growth
  • PDLB 148.96
  • DCTH N/A
  • EPS
  • PDLB 0.60
  • DCTH N/A
  • Revenue
  • PDLB $86,682,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • PDLB $10.97
  • DCTH $162.10
  • Revenue Next Year
  • PDLB $8.59
  • DCTH $32.97
  • P/E Ratio
  • PDLB $23.41
  • DCTH N/A
  • Revenue Growth
  • PDLB 18.40
  • DCTH 1068.87
  • 52 Week Low
  • PDLB $9.05
  • DCTH $7.17
  • 52 Week High
  • PDLB $14.46
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • PDLB 55.12
  • DCTH 34.31
  • Support Level
  • PDLB $13.95
  • DCTH $11.20
  • Resistance Level
  • PDLB $14.41
  • DCTH $12.72
  • Average True Range (ATR)
  • PDLB 0.22
  • DCTH 0.58
  • MACD
  • PDLB -0.00
  • DCTH -0.12
  • Stochastic Oscillator
  • PDLB 54.50
  • DCTH 22.18

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: